Clinical Trial: A Single and Multiple Dose Study to Evaluate the Safety and Effects of Inhaled ICF001 Dry Powder in Healthy Participants

U.S., Sept. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07804628) titled 'A Single and Multiple Dose Study to Evaluate the Safety and Effects of Inhaled ICF001 Dry Powder in Healthy Participants' on Aug. 31.

Brief Summary: The primary purpose of this study is to evaluate the safety, tolerability and pharmacokinetic characteristics of ICF001 following inhaled administration of single and multiple ascending doses in healthy participants.

Study Start Date: Sept., 2026

Study Type: INTERVENTIONAL

Condition: Healthy Volunteers

Intervention: DRUG: ICF001

ICF001 capsule-based inhalation powders.

DRUG: Placebo

Matching-placebo capsule-based inhalation powders.

Recruitment Status: NOT_YET_RECRUITING

Spon...